Medical Equipment Industry News

Molecular Imaging

FDA approves first PET tracer for tau Alzheimer's imaging
Enabled higher reader sensitivity and specificity in trials
PETNET Solutions and Zionexa get approval for breast cancer-specific PET imaging agent
Cerianna is the first FDA approved F-18 oncology PET agent since 2016
New research provides a sobering reality check to AI optimists
Study finds that AI can alter data and lead to major errors in images that affect diagnosis
Nuclear medical exams expected to increase with improvements to radioisotope transport
COVID-19 bottlenecks have curtailed flights and limited delivery of radiopharmaceuticals
Imaging utilization to drop more than 50% over three or four months: report
After COVID-19, radiology may never be the same again
TTG Imaging Solutions acquires Nuclear Imaging Services and NISotopes
Expands TTG footprint, broadens customer base
PET scan volumes to rise by 6-7% this year in US
In 2019 more PET scans took place in the U.S. than in any other year
Curium acquires Zevacor Molecular
Expands presence for the supply of PET and SPECT cardiac imaging
SHINE looking at European Mo-99 production: CEO
Dutch government production of the SPECT isotope slated to end in 2025
PET scan shows widowhood can up Alzheimer's risk: study
The physiological impacts of widowhood may warrant further investigation
The InterMed Group acquires Sigma Imaging Technologies
Expands geographic reach and expertise in MR, CT and PET imaging for InterMed
US Patent Office hands victory to Jubilant, invalidates Bracco patents
Ends two year legal battle over use of Jubilant generators for PET myocardial imaging
FDA says yes to new filling lines for Mo-99 production at NorthStar
Increases capacity of domestic, non-uranium-based Mo-99 for U.S. providers
Three-way collaboration to introduce radiopharmaceuticals for brain diseases
For detecting and treating Alzheimer's, Parkinsons, TBI
Imaging industry urges change in reimbursement for Alzheimer’s PET scans
Advocating for changes that would increase patient access to emerging capabilities
NTP Radioisotopes reclaims 80 percent of its share in Mo-99 market
Follows extended shutdowns and eventual reopening